Di Costanzo, Margherita (2021) Tolerogenic effect elicited by protein fraction derived from different formulas for dietary treatment of cow's milk allergy in human cells. [Tesi di dottorato]


Download (1MB) | Preview
[error in script] [error in script]
Item Type: Tesi di dottorato
Lingua: English
Title: Tolerogenic effect elicited by protein fraction derived from different formulas for dietary treatment of cow's milk allergy in human cells
Di Costanzo, Margheritamara.dicostanzo@live.it
Date: 11 April 2021
Number of Pages: 54
Institution: Università degli Studi di Napoli Federico II
Department: Scienze Mediche Traslazionali
Dottorato: Medicina clinica e sperimentale
Ciclo di dottorato: 33
Coordinatore del Corso di dottorato:
Beguinot, Francescofrancesco.beguinot@unina.it
Berni Canani, RobertoUNSPECIFIED
Date: 11 April 2021
Number of Pages: 54
Uncontrolled Keywords: cow's milk allergy, milk peptides, immune tolerance
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/38 - Pediatria generale e specialistica
Date Deposited: 20 Apr 2021 07:43
Last Modified: 07 Jun 2023 10:34
URI: http://www.fedoa.unina.it/id/eprint/13896


Several formulas are available for the dietary treatment of cow's milk allergy (CMA). Clinical data suggest potential different effect on immune tolerance elicited by these formulas. We aimed to comparatively evaluate the tolerogenic effect elicited by the protein fraction of different formulas available for the dietary treatment of CMA. Five formulas were compared: extensively hydrolyzed whey formula (EHWF), extensively hydrolyzed casein formula (EHCF), hydrolyzed rice formula (HRF), soy formula (SF), and amino acid-based formula (AAF). Formulas were reconstituted in water according to manufacturer's instructions and subjected to an in vitro infant gut simulated digestion using a sequential gastric and duodenal static model. Protein fraction was then purified and used for the experiments on non-immune and immune components of tolerance network in human enterocytes and in peripheral mononuclear blood cells (PBMCs). We assessed epithelial layer permeability and tight junction proteins (occludin and zonula occludens 1, ZO-1), mucin 5AC (Muc5AC), IL-33 and thymic stromal lymphopoietin (TSLP) in human enterocytes. In addition, Th1/Th2 cytokines response and T regulatory cells (Tregs) activation were investigated in PBMCs from IgE-mediated CMA infants. EHCF-derived protein fraction positively modulated the expression of gut barrier components (Muc5AC, occludin and ZO-1) in human enterocytes, while SF was able to stimulate only the expression of occludin. EHWF and HRF protein fractions elicited a significant increase in TSLP production, while IL-33 release was significantly increased by HRF and SF protein fractions in human enterocytes. Only EHCF-derived protein fraction elicited an increase in the production of the tolerogenic cytokines (IL-10, IFN-γ) and in the number of activated CD4+FoxP3+Tregs, through NFAT, AP1 and NF-kB1 pathway. The effect paralleled with an up-regulation of FOXP3 demethylation rate. Protein fraction from all study formulas was unable to induce Th2 cytokines production. The results suggest a different regulatory action on tolerogenic mechanisms elicited by protein fraction from different formulas commonly used for CMA management. EHCF-derived protein fraction was able to elicit tolerogenic effect through at least in part an epigenetic modulation of FOXP3 gene. These results could explain the different clinical effects observed using EHCF on immune tolerance acquisition in CMA patients and on allergy prevention in children at risk for atopy (see Graphical abstract in Figure 1).


Downloads per month over past year

Actions (login required)

View Item View Item